Business
EQT exits Galderma Group AG in full via largest sponsor-backed block trade ever
Sunshine SwissCo GmbH, an affiliate of the EQT VIII fund ("EQT VIII"), together with other selling shareholders, is pleased to announce the completion of the placement of c. 34.0 million shares (the "Shares") in Galderma Group AG (SIX: GALD) ("Galderma") for aggregate gross proceeds of c. CHF 4.9 billion via an accelerated bookbuilding process (the "Placement"). As part of the Placement, EQT VIII received gross proceeds of c. CHF 1.3 billion.
About this update from Galderma Group Ag
[{"type":"list","items":[{"val":[{"type":"text","content":"EQT completes final sell-down in Galderma, a global dermatology company delivering science-backed solutions to healthcare professionals, consumers and patients worldwide","length":169,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":169,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Under EQT's ownership, Galderma significantly accelerated revenue growth, increased investment in research and development, and built one of the broadest portfolios of clinically-proven flagship brands in dermatology. Galderma completed one of the largest IPOs in Europe in 2024, and its share price has nearly tripled since the IPO","length":336,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":336,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"The sale resulted in aggregate gross proceeds of c. CHF 4.9 billion, of which EQT VIII received c. CHF 1.3 billion. It is the largest sponsor-backed block trade in history","length":171,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":171,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"In total, EQT has realized c. CHF 21 billion / USD 26 billion of proceeds for its funds and co-investors through the sale of Galderma shares, representing the largest value-creation outcome in EQT's history","length":210,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":210,"olType":false},{"type":"text","content":"STOCKHOLM, March 13, 2026 /PRNewswire/ -- Sunshine SwissCo GmbH, an affiliate of the EQT VIII fund ("EQT VIII"), together with other selling shareholders, is pleased to announce the completion of the placement of c. 34.0 million shares (the "Shares") in Galderma Group AG (SIX: GALD) ("Galderma") for aggregate gross proceeds of c. CHF 4.9 billion via an accelerated bookbuilding process (the "Placement"). As part of the Placement, EQT VIII received gross proceeds of c. CHF 1.3 billion.","length":538,"tagName":"p"},{"type":"text","content":"The Placement was completed on 13 March 2026. Goldman Sachs International, Morgan Stanley & Co. International Plc, UBS AG, Citigroup Global Markets Limited, Jefferies GmbH, and J.P. Morgan Securities plc. acted as joint global coordinators and joint bookrunners...